- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
is a division of
- PR Newswire
- Patent Law
News of the day
Terumo Cardiovascular Systems Files Patent Infringement Complaint Against Maquet Cardiovascular LLC
2nd September 2008 ANN ARBOR, Michigan, September 2 /PRNewswire/ -- Terumo Cardiovascular Systems (Terumo CVS) announced that it filed a patent infringement complaint on August 21 in the Northern District of California against Maquet Cardiovascular LLC. The complaint alleges that Maquet's Vasoview(R) Endoscopic Vessel Harvesting Systems infringe a patent for which Terumo CVS owns the rights. The complaint also requests an injunction against further sales of the product in the U.S. (Logo:... moreIntellect Neurosciences, Inc. Obtains Pivotal European Patent Related To Monoclonal Antibody Passive Immunization Treatment Of Alzheimer's Disease
31st July 2008 NEW YORK, July 31 /PRNewswire/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS) announced today it has obtained a European patent relating to the Company's ANTISENILIN(R) monoclonal antibody platform for the treatment of Alzheimer's disease. The claims of the issued patent cover the ANTISENILIN(R) "free-end specific" antibodies that bind to beta amyloid and use of the antibodies in preventing or inhibiting the progression of Alzheimer's disease. The technology is designed to promote... moreNventa Wins European Patent Challenge Covering Lead Product Candidate HspE7 and Other HPV Therapeutics
29th July 2008 SAN DIEGO, July 29 /PRNewswire/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN) announced today that it has received a favorable decision from the Technical Board of Appeal of the European Patent Office (EPO) for the company's European Patent Number 1,002,110. This patent, which allows exclusively through 2018, covers compositions of fusion proteins comprised of a human papillomavirus (HPV) antigen fused to a heat shock protein (Hsp), as well as DNA encoding such fusion proteins. This... more PR Newswire search
Most viewed
- Neuralstem Goes to Court for Summary Judgment Against StemCells, Inc.
- Occlutech Clarifies Statement Regarding Favourable Opinion Obtained From AIPPI With Regard to Patents Held by AGA Medical
- Neptune Technologies Patent Granted for Novel Phospholipids in Multiple Diseases and Pharmaceutical Applications
- Court Determines that University of Pittsburgh and Artecel Have Sole Rights to Adipose-Derived Stem Cell Patent
- Silence Therapeutics Announces Successful Opposition of Glover Patent
More recent news
Solianis' Novel Multisensor Technology Monitors Hydration Changes in Skin - Two Patents Submitted Opening New Horizons for Cosmetic Manufacturers and Customers
24th July 2008 ZURICH, Switzerland, July 24 /PRNewswire/ -- Solianis' new patents cover the basic technology to monitor
changes in the hydration of skin at different depths and to evaluate the
impact of cosmetic...
Silence Therapeutics Announces Successful Opposition of Glover Patent
11th July 2008 LONDON, July 11 /PRNewswire/ -- Silence Therapeutics plc (London AIM: SLN), a leading European RNA
interference (RNAi) focused biotechnology company, announced today the
successful opposition of a...
Court Determines that University of Pittsburgh and Artecel Have Sole Rights to Adipose-Derived Stem Cell Patent
19th June 2008 SUNNYVALE, California, June 19 /PRNewswire/ -- Artecel, Inc., announced today that the patent inventorship litigation
concerning the foundational, composition-of-matter patent covering stem...
Oncolytics Biotech Inc. Announces Issuance of 27th U.S. Patent
20th May 2008 CALGARY, Canada, May 20 /PRNewswire/ -- Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ("Oncolytics") today
announced that it has been granted U.S. Patent 7,374,752 entitled "Reovirus
for the...
Neuralstem Goes to Court for Summary Judgment Against StemCells, Inc.
6th May 2008 ROCKVILLE, Maryland, May 6 /PRNewswire/ -- Stem cell company, Neuralstem, Inc. (Amex: CUR), today announced that
they have filed a motion to re-open the infringement lawsuit with StemCells,
Inc. and...
Occlutech Clarifies Statement Regarding Favourable Opinion Obtained From AIPPI With Regard to Patents Held by AGA Medical
17th April 2008 JENA, Germany, April 17 /PRNewswire/ -- Occlutech GmbH, the leading European manufacturer of cardiac occlusion
devices today announced a clarification of a recent news release.
In a news release...
Neptune Technologies Patent Granted for Novel Phospholipids in Multiple Diseases and Pharmaceutical Applications
27th March 2008 LAVAL, Canada, March 27 /PRNewswire/ -- Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ: NEPT -
TSX.V.NTB) announces that the European Patent Office (EPO) granted on May
31st 2007...
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us